接诊患者:低钠血症与抗利尿不当综合征(SIAD)
低钠血症是临床最常见的电解质紊乱,可影响高达30%的急性入院患者,并与显著不良临床结局相关。本文综述并比较当前关于急性和慢性低钠血症诊断与治疗的推荐、指南及文献,并通过2例病例说明,重点聚焦抗利尿不当综合征(SIAD)的诊治。理解低钠血症的病理生理,并结合低钠血症持续时间、生化严重程度、症状学及血容量状态,构成指导适当且及时管理的框架。
要点
- 低钠血症影响高达30%的急性入院患者,与显著不良临床结局相关。
- 急性或严重症状性低钠血症具有高神经并发症和死亡风险。
- 慢性低钠血症与跌倒、骨质疏松、骨折、步态不稳及认知下降风险增加相关。
核心结论
- 理解低钠血症的病理生理,并结合低钠血症持续时间、生化严重程度、症状学及血容量状态,可指导适当且及时的管理。
研究设计与样本
- 本文为综述,比较当前关于急性和慢性低钠血症诊断与治疗的推荐、指南及文献,并通过2例病例说明。
主要发现
- 低钠血症影响高达30%的急性入院患者,并与显著不良临床结局相关。
- 急性或严重症状性低钠血症具有高神经并发症和死亡风险。
- 慢性低钠血症与跌倒、骨质疏松、骨折、步态不稳及认知下降风险增加相关,并与住院时间延长及病因特异性死亡率增加相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hyponatremia is the most common electrolyte disturbance seen in clinical practice, affecting up to 30% of acute hospital admissions, and is associated with significant adverse clinical outcomes. Acute or severe symptomatic hyponatremia carries a high risk of neurological morbidity and mortality. In contrast, chronic hyponatremia is associated with significant morbidity including increased risk of falls, osteoporosis, fractures, gait instability, and cognitive decline; prolonged hospital admissions; and etiology-specific increase in mortality. In this Approach to the Patient, we review and compare the current recommendations, guidelines, and literature for diagnosis and treatment options for both acute and chronic hyponatremia, illustrated by 2 case studies. Particular focus is concentrated on the diagnosis and management of the syndrome of inappropriate antidiuresis. An understanding of the pathophysiology of hyponatremia, along with a synthesis of the duration of hyponatremia, biochemical severity, symptomatology, and blood volume status, forms the structure to guide the appropriate and timely management of hyponatremia. We present 2 illustrative cases that represent common presentations with hyponatremia and discuss the approach to management of these and other causes of hyponatremia.
引用
- Martin-Grace J, Tomkins M, O'Reilly MW, et al. Approach to the Patient: Hyponatremia and the Syndrome of Inappropriate Antidiuresis (SIAD). J Clin Endocrinol Metab. 2022. PMID: 35511757. doi:10.1210/clinem/dgac245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。